Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Women's Health

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jwh.2015.5282PMID 26889924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frequency of high-risk patients not receiving high-potency statin (from a large managed care database).

  2015cited by this paper
• Effi cacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

  2015cited by this paper
• Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

  2015cited by this paper
• HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION

  2014cited by this paper
• 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014influential reference
• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Quality of cardiovascular disease care in Ontario’s primary care practices: a cross sectional study examining differences in guideline adherence by patient sex

  2014cited by this paper
• Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?

  2014cited by this paper
• Fifteen-Year Trends in Awareness of Heart Disease in Women: Results of a 2012 American Heart Association National Survey

  2013cited by this paper
• Gender and racial disparities in adherence to statin therapy: a meta-analysis.

  2013cited by this paper
• Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy

  2012cited by this paper
• The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

  2012cited by this paper
• Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

  2011cited by this paper
• Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.

  2011cited by this paper
• Gender disparities in lipid-lowering therapy among veterans with diabetes.

  2011cited by this paper
• Estimating Causal Effects in Mediation Analysis Using Propensity Scores

  2011cited by this paper
• Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study

  2011cited by this paper
• Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe

  2011cited by this paper
• The Use of Propensity Scores in Mediation Analysis

  2011cited by this paper
• Evidence-Based Management of Statin Myopathy

  2010cited by this paper
• Patient, Physician, and Payment Predictors of Statin Adherence

  2010cited by this paper
• Recognizing and Improving Health Care Disparities in the Prevention of Cardiovascular Disease in Women

  2010cited by this paper
• Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event

  2010cited by this paper
• Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.

  2009cited by this paper
• Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease

  2009cited by this paper
• Prevalence of Musculoskeletal Pain and Statin Use

  2008cited by this paper
• The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis

  2007cited by this paper
• Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Gender disparities in the quality of cardiovascular disease care in private managed care plans.

  2007cited by this paper
• Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study

  2007cited by this paper
• Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans?

  2007cited by this paper
• Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

  2007cited by this paper
• AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.

  2006cited by this paper
• Gender disparities in lipid management: the presence of disparities depends on the quality measure.

  2006cited by this paper
• AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

  2006cited by this paper
• Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.

  2006cited by this paper
• Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.

  2006cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women

  2003cited by this paper
• ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

  2002cited by this paper
• Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity.

  2000cited by this paper
• Practical considerations on the use of the Charlson comorbidity index with administrative data bases.

  1996cited by this paper
• Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

  1991cited by this paper
• Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

  1986cited by this paper

• Lipid-lowering therapy in Switzerland: time trends in utilization and cost, 2015–2023

  2025cites this paper
• Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study

  2025cites this paper
• Sex-related disparities in hyperlipidaemia and cardiovascular risk in Sri Lanka: a cross-sectional study

  2025influential citation
• Integrating Genetic and Transcriptomic Data to Identify Genes Underlying Obesity Risk Loci

  2024cites this paper
• Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’

  2024cites this paper
• Statin therapy impact on Long-Term outcomes in acute heart Failure: Retrospective analysis of hospitalized patients

  2024cites this paper
• A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary

  2024cites this paper
• Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease.

  2024cites this paper
• PATTERNS AND GAPS IN GUIDELINE-DIRECTED STATIN USE FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN DISAGGREGATED HISPANIC AND ASIAN SUBGROUPS

  2023cites this paper
• A systematic review of disparities in the medical management of atherosclerotic cardiovascular disease in females.

  2023cites this paper
• Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging With Cardiovascular Outcomes.

  2023cites this paper
• Lower All-Cause Mortality Risk in Females and Males with Peripheral Artery Disease following Pain-Free Home-Based Exercise: A 7-Year Observational Study

  2023cites this paper
• ANTIRACIST AI: A MACHINE LEARNING MODEL USING ELECTROCARDIOGRAMS AND ECHOCARDIOGRAMS CAN DETECT TRANSTHYRETIN CARDIAC AMYLOIDOSIS AND DECREASE RACIAL BIAS IN DIAGNOSTIC TESTING

  2023cites this paper
• A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?

  2022cites this paper
• Update on Management of Cardiovascular Diseases in Women

  2022cites this paper
• Poor achievement of lipid targets after acute coronary syndrome: what can we improve?

  2022cites this paper
• LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals

  2022cites this paper
• Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013-2019.

  2021cites this paper
• Disparities in Cardiovascular Care and Outcomes for Women From Racial/Ethnic Minority Backgrounds

  2020cites this paper
• The Gut Microbiota-Produced Indole-3-Propionic Acid Confers the Antihyperlipidemic Effect of Mulberry-Derived 1-Deoxynojirimycin

  2020cites this paper
• Statin treatment and LDL target value achievement in Swiss general practice - a retrospective observational study.

  2020cites this paper
• Outcome and Cost of Optimal Control of Dyslipidemia in Adults With High Risk for Cardiovascular Disease.

  2020cites this paper
• Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016.

  2020cites this paper
• Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

  2019cites this paper
• FACTORS INFLUENCING ACHIEVEMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOALS IN MEXICO: THE INTERNATIONAL CHOLESTEROL MANAGEMENT PRACTICE STUDY.

  2019cites this paper
• Underutilization of Statin Therapy for Secondary Prevention of Cardiovascular Disease Among Older Adults

  2019cites this paper
• Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial

  2019influential citation
• Gender Differences in Outcomes Following a Pain-Free, Home-Based Exercise Program for Claudication

  2019cites this paper
• Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.

  2018cites this paper
• Sex differences in lipid and lipoprotein metabolism

  2018cites this paper
• A cross-sectional study of gender differences in lifestyle behavior and usage of medications among community-dwelling Asians towards achieving their LDL-Cholesterol treatment goals

  2017cites this paper
• Under-prescription of statins in patients with non-alcoholic fatty liver disease.

  2017cites this paper
• Racial disparities in hospitalizations, procedural treatments and mortality of patients hospitalized with atrial fibrillation.

  2014cites this paper